| | | Copy number gain | See cases | |
| | LOC130060335, LOC130060336 +242 more | Copy number gain | See cases | |
| | ADORA2B, ARHGAP44 +228 more | Duplication | not specified | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant) | not provided | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Microsatellite (frameshift variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +1 more | |
| | | Single nucleotide variant (nonsense) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Deletion (inframe_deletion) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +1 more | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Duplication (inframe_insertion) | Combined oxidative phosphorylation defect type 17 +2 more | GConflicting classifications of pathogenicity |
| | | Insertion (inframe_insertion) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Deletion (frameshift variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | not specified +2 more | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Inversion (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Indel (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Deletion (inframe_indel) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Prostate cancer, hereditary, 2 +2 more | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +3 more | |
| | | Duplication (inframe_insertion) | Inborn genetic diseases +1 more | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 +1 more | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | GConflicting classifications of pathogenicity |
| | | Deletion (inframe_deletion) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +1 more | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Deletion (frameshift variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Deletion (frameshift variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Duplication (inframe_insertion) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (synonymous variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Microsatellite (frameshift variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (splice acceptor variant) | ELAC2-related disorder | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 +1 more | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Deletion (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Microsatellite (intron variant) | Combined oxidative phosphorylation defect type 17 | |
| | | Single nucleotide variant (splice donor variant) | Inborn genetic diseases | |
| | | Single nucleotide variant (missense variant) | Combined oxidative phosphorylation defect type 17 | |